Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroleptic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03510325
What this trial is testing

Sequential Multiple-Assignment Randomized Trials to Compare Antipsychotic Treatments(SMART-CAT)

Who this might be right for
Schizophrenia
Shanghai Mental Health Center 762
Not applicableUnknownNCT02137616
What this trial is testing

Antipsychotic to Treat Psychosis Syndrome

Who this might be right for
Psychotic Disorders
Central South University 300
Not applicableStudy completedNCT00392743
What this trial is testing

Compare Two Different Brain Imaging Techniques in Healthy Volunteers and in Schizophrenic Patients

Who this might be right for
Schizophrenia
GlaxoSmithKline 60
Not applicableStudy completedNCT01544608
What this trial is testing

Observe Real-life Allocation of Atypical Antipsychotics in the Acute Inpatient Management of Schizophrenia

Who this might be right for
Schizophrenia
AstraZeneca 1,076
Large-scale testing (Phase 3)Study completedNCT00347425
What this trial is testing

Switch Study of Existing Atypical Antipsychotics to Bifeprunox

Who this might be right for
Schizophrenia and Schizoaffective Disorder
Solvay Pharmaceuticals 286
Not applicableStudy completedNCT00480168
What this trial is testing

A Prospective Study to Assess Metabolic Changes in Children and Adolescents Treated With Atypical Antipsychotics

Who this might be right for
Adverse Effects
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 50
Early research (Phase 1)Study completedNCT00946491
What this trial is testing

To Demonstrate the Relative Bioequivalency of Generic Haloperidol Tablets Versus Haldol in Normal Volunteers

Who this might be right for
Psychosis
Sandoz 30
Post-approval studies (Phase 4)Study completedNCT01726335
What this trial is testing

Switching From Oral Antipsychotics to Long-Acting Risperidone in Participants With Schizophrenia

Who this might be right for
Schizophrenia
Janssen-Cilag Ltd. 53
Large-scale testing (Phase 3)Ended earlyNCT01760993
What this trial is testing

Long-term Safety of SPD489 When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of Schizophrenia

Who this might be right for
Schizophrenia
Shire 2
Post-approval studies (Phase 4)Study completedNCT00981526
What this trial is testing

Telmisartan as an Adjunctive Treatment for Metabolic Problems in Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
University of Massachusetts, Worcester 66
Post-approval studies (Phase 4)Study completedNCT00495352
What this trial is testing

The Pharmacogenetic Study , Readiness to Change, and Pharmacological Intervention for Smoking Cessation in Schizophrenia

Who this might be right for
Tobacco DependenceSchizophrenia
Yu-Li Hospital 360
Not applicableStudy completedNCT01160991
What this trial is testing

Effect of Atypical Antipsychotic Drugs Olanzapine and Amisulpride on Glucose Metabolism

Who this might be right for
SchizophreniaDiabetesInsulin Resistance
Central Institute of Mental Health, Mannheim 10
Not applicableNot Yet RecruitingNCT07805980
What this trial is testing

A Relation Between Craving Induction and Treatment Response in Deep Transcranial Magnetic Stimulation (dTMS) for Reducing Antipsychotic-induced Weight Gain in Schizophrenia

Who this might be right for
SchizophreniaAntipsychotic Induced Weight Gain
Second Xiangya Hospital of Central South University 30
Post-approval studies (Phase 4)UnknownNCT03883204
What this trial is testing

Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 3-years Follow-up

Who this might be right for
SchizophreniaPsychotic DisordersPsychosis
Fundación Marques de Valdecilla 115
Not applicableStudy completedNCT00362804
What this trial is testing

Tetrabenazine for Partial Responders

Who this might be right for
SchizophreniaSchizoaffective Disorder
Centre for Addiction and Mental Health 41
Not applicableActive Not RecruitingNCT07351240
What this trial is testing

The Acupuncture Treatment Effect in Patients With Schizophrenia

Who this might be right for
Mental Health
Calo Psychiatric Center 100
Post-approval studies (Phase 4)Study completedNCT00000374
What this trial is testing

Treatment for First-Episode Schizophrenia

Who this might be right for
Schizophrenia
Northwell Health 125
Not applicableLooking for participantsNCT07085923
What this trial is testing

Norwegian Mental Illness Heart Health Study

Who this might be right for
Cardio Vascular DiseaseMetabolic Syndrome (MetS)Severe Mental Disorder+5 more
Madeleine Elisabeth Angelsen 70
Large-scale testing (Phase 3)Study completedNCT01281527
What this trial is testing

Paliperidone Palmitate Flexible Dosing in Schizophrenia

Who this might be right for
Schizophrenia
Janssen-Cilag International NV 1,044
Large-scale testing (Phase 3)Study completedNCT00253162
What this trial is testing

The Effectiveness and Safety of Risperidone Compared With Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder, and the Maintenance of Anti-manic Effectiveness of Risperidone Compared With Haloperidol

Who this might be right for
Bipolar DisordersManic Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 439
Next Page